FDA Device recall Z-2416-2018
Medtronic EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies and RapidRead Telemetry, D153AT…
- FDA Device
- Class II
- terminated
- Published 2018-07-18
On 2018-07-18 the FDA classified a Class II recall of Medtronic EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies and RapidRead Telemetry, D153AT… by Medtronic Cardiac Rhythm And Heart Failure Crhf, citing medtronic has become aware of a potential for loss of high voltage and anti-tachycardia pacing therapy in EnTrust and Escudo implantable cardioverter defibrillators (ICDs) as they….
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2416-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-06-21 |
| Published | 2018-07-18 |
| Last updated | 2026-09-13 11:54 UTC |
| Company | Medtronic Cardiac Rhythm And Heart Failure Crhf |
| Distribution | US |
Product
Medtronic EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies and RapidRead Telemetry, D153ATG Product Usage: The device indicated for use in ICD patients with atrial tachyarrhythmias, or who are at significant risk of developing atrial tachyarrhythmias. The implantable cardioverter defibrillator is intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life threatening ventricular arrhythmias.
Reason
Medtronic has become aware of a potential for loss of high voltage and anti-tachycardia pacing therapy in EnTrust and Escudo implantable cardioverter defibrillators (ICDs) as they near elective replacement indicator (ERI) voltage. Under certain circumstances, the device may display an immediate End of Life (EOL) Observation with no prior ERI alert. Though no ERI alert is triggered, there may not be enough remaining battery capacity to charge the high voltage circuits, resulting in an excessive charge time EOL Observation, leading to a loss of high voltage and anti-tachycardia pacing therapy.
Identifiers
| code_info | Product UPN/GTIN: 00721902791130 Serial Numbers: PNR100502Q PNR100510Q PNR100522Q PNR100535Q Product UPN/GTIN:…Product UPN/GTIN: 00721902791130 Serial Numbers: PNR100502Q PNR100510Q PNR100522Q PNR100535Q Product UPN/GTIN: 00721902791147 Serial Numbers: PNR100129Q PNR100130Q PNR100131Q PNR100134Q PNR100135Q PNR100138Q PNR100139Q PNR100141Q PNR100143Q PNR100144Q PNR100146Q PNR100147Q PNR100150Q PNR100151Q PNR100153Q PNR100154Q PNR100155Q PNR100156Q PNR100157Q PNR100160Q PNR100161Q PNR100162Q PNR100163Q PNR100164Q PNR100165Q PNR100166Q PNR100167Q PNR100168Q PNR100169Q PNR100174Q PNR100175Q PNR100176Q PNR100178Q PNR100182Q PNR100183Q PNR100184Q PNR100185Q PNR100188Q PNR100191Q PNR100192Q PNR100193Q PNR100195Q PNR100196Q PNR100197Q PNR100198Q PNR100200Q PNR100204Q PNR100208Q PNR100210Q PNR100211Q PNR100212Q PNR100213Q PNR100215Q PNR100216Q PNR100217Q PNR100218Q PNR100219Q PNR100220Q PNR100221Q PNR100222Q PNR100223Q PNR100224Q PNR100225Q PNR100226Q PNR100227Q PNR100228Q PNR100229Q PNR100230Q PNR100233Q PNR100234Q PNR100 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2416-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.